Trial · NCT01589302
Adverse events158
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
81 to 100 of 158
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Febrile Neutropenia | Blood and lymphatic system disorders | Treatment (Ibrutinib) | 5 | 152 | 5 |
| serious | Hemolytic Uremic Syndrome | Blood and lymphatic system disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Lymph Node Pain | Blood and lymphatic system disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Atrial Fibrillation | Cardiac disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Cardiac Arrest | Cardiac disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Cardiac Disorders-other | Cardiac disorders | Treatment (Ibrutinib) | 1 | 152 | 4 |
| serious | Myocardial Infarction | Cardiac disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Ventricular Arrythmia | Cardiac disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Blurred Vision | Eye disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Colonic Perforation | Gastrointestinal disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Diarrhea | Gastrointestinal disorders | Treatment (Ibrutinib) | 3 | 152 | 3 |
| serious | Enterocolitis | Gastrointestinal disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Esophageal Ulcer | Gastrointestinal disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Gastric Hemorrhage | Gastrointestinal disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Gastrointestinal Disorders-other | Gastrointestinal disorders | Treatment (Ibrutinib) | 3 | 152 | 4 |
| serious | Jejunal Hemorrhage | Gastrointestinal disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Small Intestinal Obstruction | Gastrointestinal disorders | Treatment (Ibrutinib) | 2 | 152 | 2 |
| serious | Chills | Gastrointestinal disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Death NOS | General disorders | Treatment (Ibrutinib) | 5 | 152 | 5 |
| serious | Edema Limbs | General disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01589302/events?page=5